Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j

Comments

Popular posts from this blog

Gurugram Man Kidnaps Toddler For Childless Sister, Arrested: Cops

Cannes 2024: Sobhita Adds Sparkle And Glam. See French Riviera Album